リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Ror1 is expressed inducibly by Notch and hypoxia signaling and regulates stem cell-like property of glioblastoma cells」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Ror1 is expressed inducibly by Notch and hypoxia signaling and regulates stem cell-like property of glioblastoma cells

Ishikawa, Tomohiro Ogura, Yasuka Tanaka, Kazuhiro Nagashima, Hiroaki Sasayama, Takashi Endo, Mitsuharu Minami, Yasuhiro 神戸大学

2023.02

概要

Ror1 plays a crucial role in cancer progression by regulating cell proliferation and migration. Ror1 is expressed abundantly in various types of cancer cells and cancer stem-like cells. However, the molecular mechanisms regulating expression of Ror1 in these cells remain largely unknown. Ror1 and its putative ligand Wnt5a are expressed highly in malignant gliomas, especially in glioblastomas, and the extents of Ror1 expression are correlated positively with poorer prognosis in patients with gliomas. We show that Ror1 expression can be upregulated in glioblastoma cells under spheroid culture, but not adherent culture conditions. Notch and hypoxia signaling pathways have been shown to be activated in spheroid-forming glioblastoma stem-like cells (GSCs), and Ror1 expression in glioblastoma cells is indeed suppressed by inhibiting either Notch or hypoxia signaling. Meanwhile, either forced expression of the Notch intracellular domain (NICD) in or hypoxic culture of glioblastoma cells result in enhanced expression of Ror1 in the cells. Consistently, we show that both NICD and hypoxia-inducible factor 1 alpha bind to upstream regions within the Ror1 gene more efficiently in GSCs under spheroid culture conditions. Furthermore, we provide evidence indicating that binding of Wnt5a to Ror1, upregulated by Notch and hypoxia signaling pathways in GSCs, might promote their spheroid-forming ability. Collectively, these findings indicate for the first time that Notch and hypoxia signaling pathways can elicit a Wnt5a–Ror1 axis through transcriptional activation of Ror1 in glioblastoma cells, thereby promoting their stem cell-like property.

論文の公開元へ

この論文で使われている画像

関連論文

関連論文をもっと見る

参考文献

1. Taal W, Bromberg JE, van den Bent MJ. Chemotherapy in glioma. CNS Oncol. 2015;4:179-192.

2. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396-401.

3. Bao SD, Wu QL, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage re- sponse. Nature. 2006;444:756-760.

4. Chen J, Li YJ, Yu TS, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012;488: 522-+.

5. Prager BC, Bhargava S, Mahadev V, Hubert CG, Rich JN. Glioblastoma stem cells: driving resilience through chaos. Trends Cancer. 2020;6:223-235.

6. Teodorczyk M, Schmidt MHH. Notcning on cancer's door: Notch signaling in brain tumors. Front Oncol. 2015;4:14.

7. Bazzoni R, Bentivegna A. Role of Notch signaling pathway in glio- blastoma pathogenesis. Cancer. 2019;11:25.

8. Kumar V, Vashishta M, Kong L, et al. The role of Notch, hedgehog, and Wnt signaling pathways in the resistance of tumors to antican- cer therapies. Front Cell Dev Biol. 2021;9:24.

9. Endo M, Kamizaki K, Minami Y. The Ror-family receptors in devel- opment, tissue regeneration and age-related disease. Front Cell Dev Biol. 2022;10:891763.

10. Minami Y, Oishi I, Endo M, Nishita M. Ror-family receptor tyro- sine kinases in noncanonical Wnt signaling: their implications in developmental morphogenesis and human diseases. Dev Dyn. 2010;239:1-15.

11. Kamizaki K, Doi R, Hayashi M, et al. The Ror1 receptor tyro- sine kinase plays a critical role in regulating satellite cell pro- liferation during regeneration of injured muscle. J Biol Chem. 2017;292:15939-15951.

12. Saji T, Nishita M, Ogawa H, et al. Critical role of the Ror-family of receptor tyrosine kinases in invasion and proliferation of malignant pleural mesothelioma cells. Genes Cells. 2018;23:606-613.

13. Zhao YM, Zhang DY, Guo Y, et al. Tyrosine kinase ROR1 as a target for anti-cancer therapies. Front Oncol. 2021;11:680834.

14. Endo M, Doi R, Nishita M, Minami Y. Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex. J Cell Sci. 2012;125:2017-2029.

15. Borcherding N, Kusner D, Liu GH, Zhang WZ. ROR1, an embry- onic protein with an emerging role in cancer biology. Protein Cell. 2014;5:496-502.

16. Zhang SP, Chen LG, Cui B, et al. ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth. PLoS One. 2012;7:12.

17. Hasan MK, Yu J, Chen L, et al. Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells. Leukemia. 2017;31:2615-2622.

18. Cui B, Zhang SP, Chen LG, et al. Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis. Cancer Res. 2013;73:3649-3660.

19. Karvonen H, Arjama M, Kaleva L, et al. Glucocorticoids induce dif- ferentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness. Cell Death Dis. 2020;11:12.

20. Jung EH, Lee HN, Han GY, Kim MJ, Kim CW. Targeting ROR1 inhib- its the self-renewal and invasive ability of glioblastoma stem cells. Cell Biochem Funct. 2016;34:149-157.

21. Yamaguchi T, Yanagisawa K, Sugiyama R, et al. NKX2-1/TITF1/TTF- 1-induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma. Cancer Cell. 2012;21:348-361.

22. Li P, Harris D, Liu ZM, Liu J, Keating M, Estrov Z. Stat3 activates the receptor tyrosine kinase like orphan Receptor-1 gene in chronic lymphocytic leukemia cells. PLoS One. 2010;5:11.

23. Ikeda T, Nishita M, Hoshi K, Honda T, Kakeji Y, Minami Y. Mesenchymal stem cell-derived CXCL16 promotes progression of gastric cancer cells by STAT3-mediated expression of Ror1. Cancer Sci. 2020;111:1254-1265.

24. Endo M, Tanaka Y, Otsuka M, Minami Y. E2F1-Ror2 signaling me- diates coordinated transcriptional regulation to promote G1/S phase transition in bFGF-stimulated NIH/3T3 fibroblasts. FASEB J. 2020;34:3413-3428.

25. Bowman RL, Wang QH, Carro A, Verhaak RGW, Squatrito M. GlioVis data portal for visualization and analysis of brain tumor ex- pression datasets. Neuro Oncol. 2017;19:139-141.

26. Ishiguro T, Ohata H, Sato A, Yamawaki K, Enomoto T, Okamoto K. Tumor-derived spheroids: relevance to cancer stem cells and clini- cal applications. Cancer Sci. 2017;108:283-289.

27. Hu YY, Zheng MH, Cheng G, et al. Notch signaling contributes to the maintenance of both normal neural stem cells and patient- derived glioma stem cells. BMC Cancer. 2011;11:13.

28. Colwell N, Larion M, Giles AJ, et al. Hypoxia in the glioblastoma mi- croenvironment: shaping the phenotype of cancer stem-like cells. Neuro Oncol. 2017;19:887-896.

29. Boyd NH, Tran AN, Bernstock JD, et al. Glioma stem cells and their roles within the hypoxic tumor microenvironment. Theranostics. 2021;11:665-683.

30. Borggrefe T, Oswald F. The Notch signaling pathway: tran- scriptional regulation at Notch target genes. Cell Mol Life Sci. 2009;66:1631-1646.

31. Li Z, Bao S, Wu Q, et al. Hypoxia-inducible factors regulate tumori- genic capacity of glioma stem cells. Cancer Cell. 2009;15:501-513.

32. Fultang N, Illendula A, Chen B, et al. Strictinin, a novel ROR1- inhibitor, represses triple negative breast cancer survival and mi- gration via modulation of PI3K/AKT/GSK3 beta activity. PLoS One. 2019;14:e0217789.

33. Pu P, Zhang Z, Kang C, et al. Downregulation of Wnt2 and beta- catenin by siRNA suppresses malignant glioma cell growth. Cancer Gene Ther. 2009;16:351-361.

34. Zhu TS, Costello MA, Talsma CE, et al. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Res. 2011;71:6061-6072.

35. Yu JB, Jiang H, Zhan RY. Aberrant Notch signaling in glioblastoma stem cells contributes to tumor recurrence and invasion. Mol Med Rep. 2016;14:1263-1268.

36. Wang J, Xu SL, Duan JJ, et al. Invasion of white matter tracts by gli- oma stem cells is regulated by a NOTCH1-SOX2 positive-feedback loop. Nat Neurosci. 2019;22:91-105.

37. Qiang L, Wu T, Zhang HW, et al. HIF-1 alpha is critical for hypoxia- mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway. Cell Death Differ. 2012;19:284-294.

38. Karvonen H, Perttila R, Niininen W, et al. Wnt5a and ROR1 acti- vate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting. Oncogene. 2019;38:3288-3300.

39. Raivola J, Dini A, Salokas K, et al. New insights into the molecu- lar mechanisms of ROR1, ROR2, and PTK7 signaling from the pro- teomics and pharmacological modulation of ROR1 interactome. Cell Mol Life Sci. 2022;79:276.

参考文献をもっと見る